Pharma tax news - Vol. 5, No. 4 - March 2006

Print-friendly version

Email to a colleague

New IRS Chief Counsel advice signals possible change in IRS’ treatment of related party receipts for R&D credit

Download Pharma Tax News - Vol. 5, No. 4 (72 Kbytes)

Publications Search Page

Contacts

Global

Simon Friend: Pharmaceuticals and life sciences leader; Tel: +44 (20) 7213 4875
Mike Swanick: Pharmaceuticals and life sciences tax leader; Tel: +1 (267) 330 6060
Steve Arlington: Pharmaceuticals and life sciences advisory leader; Tel: +44 (20) 7804 3997

Privacy Legal About site provider Email Webmaster Territory sites Site map RSS

© 2006-2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.